Reports from Pharmaceutical Manufacturers or Consumers

The Prescription Drug Price Transparency Act requires prescription drug manufacturers to report new specialty prescription drugs, submit annual reports on any drugs with large price increases over the past year, and report any planned large price increases. The Oregon Drug Price Transparency Program also requests reports from consumers about cost increases they experience for prescriptions. The submitted information is updated daily and can be explored below.

IMPORTANT: The information available here was submitted by manufacturers or consumers. The department cannot confirm the accuracy and validity of reported information. Information provided by manufacturers may be inaccurate or incomplete.

This page contains all of the publicly available content in reports received by the Oregon Drug Price Transparency Program. Information claimed by a manufacturer to be trade secret will not be posted unless a final determination to disclose has been made by the department or the director. Any information claimed to be a trade secret and determined by the department to be exempt from disclosure will not be directly posted; instead, they will be generally described in brackets and include an explanation for the determination.

To review this information, we suggest selecting a particular drug. Manufacturer reports in the Filing Complete status will have the most information displayed. You can also select Consumer Notifications to see the information consumers have reported.

Note: Annual price increase reports received on or after Feb. 21, 2024, are not required to provide the same data as reports received before that date. Refer to DFR Bulletin 2024-3 for details about this change. When a data element was not provided, there will be a message stating “Voluntary data not provided" for that data element.